Effect of Bifidobacterium Longum BB536 Plus Lactoferrin in the Treatment of Irritable Bowel Syndrome (IBS). A Double Blind Clinical Trial

被引：0
|
作者：
Biviano, Ivano [1 ]
Rossi, Sara [1 ]
Badiali, Danilo [1 ]
Pallotta, Nadia [1 ]
Piacentino, Daria [1 ]
Enrico, Corazziari S. [1 ]
机构：
[1] Univ Roma La Sapienza, Internal Med & Med Specialties, Rome, Italy
来源：
JOURNAL OF CLINICAL GASTROENTEROLOGY | 2018年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [41] In vitro inhibitory activity of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 alone or in combination against bacterial and Candida reference strains and clinical isolates
    Inturri, Rosanna
    Trovato, Laura
    Li Volti, Giovanni
    Oliveri, Salvatore
    Blandino, Giovanna
    HELIYON, 2019, 5 (11)
  • [42] Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial
    van Tilburg, Miranda A. L.
    Palsson, Olafur S.
    Ringel, Yehuda
    Whitehead, William E.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2014, 22 (01) : 17 - 20
  • [43] CLINICAL AND FUNCTIONAL-EVALUATION OF OCTILONIUM BROMIDE IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME - A DOUBLE-BLIND CONTROLLED TRIAL
    BALDI, F
    CORINALDES, R
    FERRARINI, F
    BALESTRA, R
    BRUNETTI, G
    CASSAN, M
    BARBARA, L
    CLINICAL TRIALS JOURNAL, 1983, 20 (02) : 77 - 88
  • [44] Effects of propolis supplementation on irritable bowel syndrome with constipation (IBS-C) and mixed (IBS-M) stool pattern: A randomized, double-blind clinical trial
    Miryan, Mahsa
    Soleimani, Davood
    Alavinejad, Pejman
    Abbaspour, Mohammadreza
    Ostadrahimi, Alireza
    FOOD SCIENCE & NUTRITION, 2022, 10 (06): : 1899 - 1907
  • [45] Correction to: Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
    Massimiliano Ruscica
    Chiara Pavanello
    Sara Gandini
    Chiara Macchi
    Margherita Botta
    Daria Dall’Orto
    Marina Del Puppo
    Marco Bertolotti
    Raffaella Bosisio
    Giuliana Mombelli
    Cesare R. Sirtori
    Laura Calabresi
    Paolo Magni
    Nutrition Journal, 18
  • [46] EFFECT OF FECAL MICROBIOTA TRANSPLANTATION (FMT) ON IRRITABLE BOWEL SYNDROME (IBS): A RANDOMIZED, PLACEBOCONTROLLED, DOUBLE-BLIND STUDY
    Aumpan, Natsuda
    Pomthisam, Bubpha
    Chonprasertsuk, Soonthom
    Siramolpiwat, Sith
    Bhanthumkomol, Patommatat
    Nunanan, Pongjarat
    Issriyakulkarn, Navapan
    Mahachai, Varocha
    Vilaichone, Ratha-Korn
    GASTROENTEROLOGY, 2022, 162 (07) : S936 - S936
  • [47] Synbiotics in irritable bowel syndrome: A double blind prospective randomised controlled trial
    Barker, P
    McNaught, CE
    Anderson, ADG
    Mitchell, CJ
    MacFie, J
    GUT, 2003, 52 : A11 - A11
  • [48] LONGTERM TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CIMETROPIUM BROMIDE, A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL
    DOBRILLA, G
    PIAZZI, L
    IMBIMBO, BP
    BENSI, G
    GUT, 1989, 30 (05) : A714 - A714
  • [49] Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable Bowel syndrome in adolescents
    Bahar, Ron J.
    Collins, Brynie S.
    Steinmetz, Barry
    Ament, Marvin E.
    JOURNAL OF PEDIATRICS, 2008, 152 (05): : 685 - 689
  • [50] PSYCHOPHARMACOLOGIC DRUGS IN THE TREATMENT OF THE IRRITABLE BOWEL SYNDROME - A DOUBLE-BLIND-STUDY OF THE EFFECT OF TRIMIPRAMINE
    MYREN, J
    LOVLAND, B
    LARSSEN, SE
    LARSEN, S
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1984, 20 (03): : 117 - 123
12345